Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1993 Jun;142(6):1848–1857.

Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis.

T Tsuruta 1, T Yamamoto 1, S Matsubara 1, S Nagasawa 1, S Tanase 1, J Tanaka 1, K Takagi 1, T Kambara 1
PMCID: PMC1886998  PMID: 8506953

Abstract

The complement C4-derived anaphylatoxin, C4a, possesses a strong chemotaxis inhibitory capacity to blood monocytes at concentrations as low as 10(-16) mol/L. In our study, treatment with carboxypeptidase B to convert it to C4a des Arg77 decreased the inhibitory activity to less than 1/1,000. The extraordinary inhibitory capacity of C4a suggests the presence of an amplification mechanism in this inhibition. Indeed, we found that the conditioned media of peripheral blood mononuclear cells or monocyte/macrophage lineage cell lines (U937 and THP-1 cells) preincubated with 10(-16) mol/L C4a for 5 minutes or more at 37 C possessed the inhibitory capacity 100,000-fold stronger than the original activity of C4a. The monocyte-derived chemotaxis inhibitory factor seemed monocyte-specific. This cell-derived factor was sensitive to treatment with trypsin and chymotrypsin and immunologically distinct from C4a. The apparent molecular size of the monocyte factor was estimated to be approximately 20 kd by gel filtration. These results indicate that C4a anaphylatoxin induces the release from monocytes of a protein with inhibitory activity for monocyte chemotaxis.

Full text

PDF
1848

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boulay F., Tardif M., Brouchon L., Vignais P. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem Biophys Res Commun. 1990 May 16;168(3):1103–1109. doi: 10.1016/0006-291x(90)91143-g. [DOI] [PubMed] [Google Scholar]
  2. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  3. Cianciolo G. J., Snyderman R. Monocyte responsiveness to chemotactic stimuli is a property of a subpopulation of cells that can respond to multiple chemoattractants. J Clin Invest. 1981 Jan;67(1):60–68. doi: 10.1172/JCI110033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cooper N. R. The classical complement pathway: activation and regulation of the first complement component. Adv Immunol. 1985;37:151–216. doi: 10.1016/s0065-2776(08)60340-5. [DOI] [PubMed] [Google Scholar]
  5. Falk W., Goodwin R. H., Jr, Leonard E. J. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods. 1980;33(3):239–247. doi: 10.1016/0022-1759(80)90211-2. [DOI] [PubMed] [Google Scholar]
  6. Fernandez H. N., Henson P. M., Otani A., Hugli T. E. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol. 1978 Jan;120(1):109–115. [PubMed] [Google Scholar]
  7. Fernandez H. N., Hugli T. E. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a. J Immunol. 1976 Nov;117(5 Pt 1):1688–1694. [PubMed] [Google Scholar]
  8. Gerard N. P., Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature. 1991 Feb 14;349(6310):614–617. doi: 10.1038/349614a0. [DOI] [PubMed] [Google Scholar]
  9. Goodman M. G., Chenoweth D. E., Weigle W. O. Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors. J Exp Med. 1982 Sep 1;156(3):912–917. doi: 10.1084/jem.156.3.912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Goodman M. G., Chenoweth D. E., Weigle W. O. Potentiation of the primary humoral immune response in vitro by C5a anaphylatoxin. J Immunol. 1982 Jul;129(1):70–75. [PubMed] [Google Scholar]
  11. Gorski J. P., Hugli T. E., Müller-Eberhard H. J. Characterization of human C4a anaphylatoxin. J Biol Chem. 1981 Mar 25;256(6):2707–2711. [PubMed] [Google Scholar]
  12. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  13. Kohrogi H., Graf P. D., Sekizawa K., Borson D. B., Nadel J. A. Neutral endopeptidase inhibitors potentiate substance P- and capsaicin-induced cough in awake guinea pigs. J Clin Invest. 1988 Dec;82(6):2063–2068. doi: 10.1172/JCI113827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kukita I., Yamamoto T., Kawaguchi T., Kambara T. Fifth component of complement (C5)-derived high-molecular-weight macrophage chemotactic factor in normal guinea pig serum. Inflammation. 1987 Dec;11(4):459–479. doi: 10.1007/BF00915989. [DOI] [PubMed] [Google Scholar]
  15. MUELLER-EBERHARD H. J., LEPOW I. H. C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT. J Exp Med. 1965 May 1;121:819–833. doi: 10.1084/jem.121.5.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Matsubara S., Yamamoto T., Tsuruta T., Takagi K., Kambara T. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities. Am J Pathol. 1991 May;138(5):1279–1291. [PMC free article] [PubMed] [Google Scholar]
  17. Moon K. E., Gorski J. P., Hugli T. E. Complete primary structure of human C4a anaphylatoxin. J Biol Chem. 1981 Aug 25;256(16):8685–8692. [PubMed] [Google Scholar]
  18. Morgan E. L., Thoman M. L., Weigle W. O., Hugli T. E. Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses. J Immunol. 1983 Mar;130(3):1257–1261. [PubMed] [Google Scholar]
  19. Morgan E. L., Thoman M. L., Weigle W. O., Hugli T. E. Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses. J Immunol. 1983 Mar;130(3):1257–1261. [PubMed] [Google Scholar]
  20. Myers P. R., Wright T. F., Tanner M. A., Adams H. R. EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin. Am J Physiol. 1992 Mar;262(3 Pt 2):H710–H718. doi: 10.1152/ajpheart.1992.262.3.H710. [DOI] [PubMed] [Google Scholar]
  21. Payan D. G., Trentham D. E., Goetzl E. J. Modulation of human lymphocyte function by C3a and C3a(70-77). J Exp Med. 1982 Sep 1;156(3):756–765. doi: 10.1084/jem.156.3.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Porath J., Axen R., Ernback S. Chemical coupling of proteins to agarose. Nature. 1967 Sep 30;215(5109):1491–1492. doi: 10.1038/2151491a0. [DOI] [PubMed] [Google Scholar]
  23. Ross S. C., Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 1984 Sep;63(5):243–273. [PubMed] [Google Scholar]
  24. Snyderman R., Fudman E. J. Demonstration of a chemotactic factor receptor on macrophages. J Immunol. 1980 Jun;124(6):2754–2757. [PubMed] [Google Scholar]
  25. Spilberg I., Mehta J., Daughaday C., Simchowitz L. Determination of a specific receptor for formyl-methionyl-leucyl-phenylalanine on th pulmonary alveolar macrophage and its relationship to chemotaxis and superoxide production. J Lab Clin Med. 1981 May;97(5):602–609. [PubMed] [Google Scholar]
  26. Takahashi K., Nagasawa S., Koyama J. The NH-2-terminal sequences of a subunit of the first component of human complement, C1s, and its activated form, C1s. FEBS Lett. 1975 Feb 15;50(3):330–333. doi: 10.1016/0014-5793(75)80521-7. [DOI] [PubMed] [Google Scholar]
  27. Webster G. C. Comparison of direct spectrophotometric methods for the measurement of protein concentration. Biochim Biophys Acta. 1970 May 26;207(2):371–373. doi: 10.1016/0005-2795(70)90031-0. [DOI] [PubMed] [Google Scholar]
  28. Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973 Feb 1;137(2):387–410. doi: 10.1084/jem.137.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES